E. Ohman J or Asset Management AB boosted its position in Colgate-Palmolive (NYSE:CL - Free Report) by 1,108.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 386,730 shares of the company's stock after purchasing an additional 354,730 shares during the quarter. E. Ohman J or Asset Management AB's holdings in Colgate-Palmolive were worth $35,158,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently made changes to their positions in the company. Welch Group LLC grew its holdings in shares of Colgate-Palmolive by 1.5% during the 4th quarter. Welch Group LLC now owns 631,619 shares of the company's stock worth $57,345,000 after purchasing an additional 9,137 shares during the period. Commonwealth Financial Services LLC raised its holdings in Colgate-Palmolive by 4.5% in the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock valued at $247,000 after acquiring an additional 118 shares in the last quarter. Calamos Wealth Management LLC raised its stake in shares of Colgate-Palmolive by 1.7% in the 4th quarter. Calamos Wealth Management LLC now owns 16,253 shares of the company's stock valued at $1,478,000 after purchasing an additional 277 shares in the last quarter. Calamos Advisors LLC lifted its position in shares of Colgate-Palmolive by 0.3% during the fourth quarter. Calamos Advisors LLC now owns 302,648 shares of the company's stock worth $27,514,000 after purchasing an additional 805 shares during the last quarter. Finally, Trust Point Inc. grew its stake in Colgate-Palmolive by 2.1% in the fourth quarter. Trust Point Inc. now owns 20,327 shares of the company's stock worth $1,848,000 after purchasing an additional 417 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.
Analysts Set New Price Targets
Several analysts recently commented on CL shares. Stifel Nicolaus decreased their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a report on Monday. UBS Group decreased their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a report on Monday. Raymond James reaffirmed an "outperform" rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday. Barclays decreased their price target on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a report on Friday, January 17th. Finally, Royal Bank of Canada restated a "sector perform" rating and set a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of "Hold" and an average price target of $101.16.
View Our Latest Research Report on Colgate-Palmolive
Colgate-Palmolive Stock Performance
Colgate-Palmolive stock traded down $0.07 during midday trading on Wednesday, hitting $86.43. The stock had a trading volume of 1,601,295 shares, compared to its average volume of 5,214,424. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 52-week low of $82.68 and a 52-week high of $109.30. The company has a market capitalization of $70.61 billion, a PE ratio of 24.55, a P/E/G ratio of 3.61 and a beta of 0.44. The firm's fifty day moving average is $90.98 and its two-hundred day moving average is $96.99.
Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the company posted $0.87 EPS. On average, research analysts forecast that Colgate-Palmolive will post 3.74 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.31%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio is currently 56.82%.
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.